Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

23andMe Gets Snubbed As Wirecutter Ranks Ancestry Testing Services

The Wirecutter, a popular product recommendation site, recently offered reviews about the leading genetic ancestry testing services. The big surprise? 23andMe, the popular genomics company, was not listed as a top pick. Instead, the site ranked Ancestry.com and Family Tree DNA as the best picks.

The Wirecutter’s decision not to recommend 23andMe had to do with how the company collects biomedical data about its customers. The basic testing kit from 23andMe gives results about your ancestry and costs $100. According to the Wirecutter’s research, however, 23andMe tests for both your ancestry and your genetic health when you send them your saliva. Though receiving the health results — indicating whether you may have a hereditary risk for a particular disease, for example — costs an additional $100, 23andMe can sell your biomedical data if you haven’t purchased the health test.

“The problem is that if you’ve paid for just the ancestry test and signed the consent form, you’ve granted access not just to your ancestry data but to your biomedical data, which you’d have no reasonable way of knowing was even obtained,” the Wirecutter wrote.

A spokeswoman for 23andMe said that it performs both the ancestry and health tests when they receive your saliva as a convenience — so that if you decide later you want the health test in addition to the ancestry test, they already have the results on file.

23andMe recently posted a discredited theory about the genetic heritage of Ashekenazi Jews on its website, telling some users that they may descended from a semi-nomadic tribe from Central Asia.

Contact Ari Feldman at feldman@forward.com or on Twitter @aefeldman.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version